A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study

Jonathan Tang, William Fraser, Jonathan Phillips, Isabelle Piec, Rachel Dunn, Catriona Keerie, Steff Lewis, Stuart Ralston

Research output: Contribution to conferenceAbstract

Original languageEnglish
Publication statusPublished - 2023

Cite this